Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Oct;60(4):589–591. doi: 10.1038/bjc.1989.319

Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.

C W Janssen Jr 1, R T Lie 1, H Maartmann-Moe 1, R Matre 1
PMCID: PMC2247116  PMID: 2803929

Abstract

The preoperative concentrations of IgG were lower (P less than 0.002) and the concentrations of C4 and C1-INH higher (P less than 0.01 and P less than 0.001) in 29 patients with recurrence after potentially curative resection of gastric carcinoma, than in 31 patients alive and disease-free 5 years after surgery. These differences between the two groups of patients were consistent within each of six groups of disease extent. In each of the two groups of patients, the preoperative concentrations of IgG, C4 and C1-INH had no significant variation with the extent of disease (P greater than 0.05 or greater). Of our variables, C1-INH was the most potent prognosticator and discriminated between patients with and without recurrence with 80% accuracy. Furthermore, the predictive prognostic value of C1-INH at the time of surgery was superior to the prognostic value of the extent of disease (F values 27.00 and 12.69). Apparently, the preoperative C1-INH concentration is an essential and independent prognostic parameter of gastric carcinoma. We assume that C1-INH reflects an additional prognostic feature appropriate to the tumour or the host. Our finding that the interval between surgery and death from recurrence had an inverse relation to the preoperative C1-INH concentration also supports this assumption.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astrup J., Colstrup H., Frandsen B. Complement C1-inactivator in the serum of patients with malignant disease. Acta Radiol Ther Phys Biol. 1977 Oct;16(5):394–400. doi: 10.3109/02841867709133960. [DOI] [PubMed] [Google Scholar]
  2. Bach-Martensen N., Osther K., Stroyer I. Letter: C1-esterase inactivators and C4 in malignant diseases. Lancet. 1975 Sep 13;2(7933):499–500. doi: 10.1016/s0140-6736(75)90571-1. [DOI] [PubMed] [Google Scholar]
  3. Gamel J., Seddon J., Polivogianis L., Albert D., Greenberg R. A method for assessing potential bias among cancer patients recorded as "dead of other causes." Application to cases of intraocular melanoma. Cancer. 1986 Jun 1;57(11):2246–2249. doi: 10.1002/1097-0142(19860601)57:11<2246::aid-cncr2820571130>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Hartley L. C., Evans E., Windsor C. J. Factors influencing prognosis in gastric cancer. Aust N Z J Surg. 1987 Jan;57(1):5–9. doi: 10.1111/j.1445-2197.1987.tb01230.x. [DOI] [PubMed] [Google Scholar]
  5. Janssen C. W., Jr, Maartmann-Moe H., Lie R. T. Concentrations of serum proteins and erythrocyte sedimentation rate in patients with different histological types of gastric carcinoma. Eur J Surg Oncol. 1987 Jun;13(3):207–211. [PubMed] [Google Scholar]
  6. Janssen C. W., Jr, Maartmann-Moe H., Lie R. T. Preoperative prediction of extent and prognosis of gastric carcinoma by four serum proteins and erythrocyte sedimentation rate. Eur J Surg Oncol. 1987 Aug;13(4):285–295. [PubMed] [Google Scholar]
  7. Janssen C. W., Jr, Tönder O., Matre R. Stage-related correlations between immunoglobulins and complement components in preoperative sera from patients with gastric carcinoma. Eur J Cancer Clin Oncol. 1983 Nov;19(11):1601–1605. doi: 10.1016/0277-5379(83)90092-5. [DOI] [PubMed] [Google Scholar]
  8. Janssen C. W., Jr, Tønder O., Matre R. The prognostic value of preoperative serum immunoglobulin and complement component concentrations in patients with gastric carcinoma. Acta Chir Scand. 1985;151(1):57–61. [PubMed] [Google Scholar]
  9. Koga T., Kano T., Souda K., Oka N., Inokuchi K. The clinical usefulness of preoperative CEA determination in gastric cancer. Jpn J Surg. 1987 Sep;17(5):342–347. doi: 10.1007/BF02470632. [DOI] [PubMed] [Google Scholar]
  10. Koller M. E., Haneberg B., Matre R., Finne P. H., Romslo I. Lysozyme and complement factors in sera from children with acute lymphoblastic leukemia. Acta Paediatr Scand. 1979 Mar;68(2):273–274. doi: 10.1111/j.1651-2227.1979.tb05001.x. [DOI] [PubMed] [Google Scholar]
  11. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  12. Nielsen J., Aagaard J., Toftgaard C. Gastric cancer with special reference to prognostic factors. A review of 779 cases. Acta Chir Scand. 1985;151(1):49–55. [PubMed] [Google Scholar]
  13. Shimizu N., Wakatsuki T., Murakami A., Yoshioka H., Hamazoe R., Kanayama H., Maeta M., Koga S. Carcinoembryonic antigen in gastric cancer patients. Oncology. 1987;44(4):240–244. doi: 10.1159/000226486. [DOI] [PubMed] [Google Scholar]
  14. Sobin L. H., Hermanek P., Hutter R. V. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer. 1988 Jun 1;61(11):2310–2314. doi: 10.1002/1097-0142(19880601)61:11<2310::aid-cncr2820611127>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES